The PROPEL Family of sinus implants are intended to deliver a steroid drug locally and maintain the sinus opening following sinus surgery in patients 18 years of age or older: PROPEL in the ethmoid sinus, PROPEL Mini in the ethmoid sinus and frontal sinus opening and PROPEL Contour in the frontal and maxillary sinus openings. Patients allergic to the drug (mometasone furoate) or ingredients of the implant should not receive PROPEL. It is not known if the implant is safe and effective in women that are pregnant or nursing. Common side effects include infection, headache, and nose bleeds. Risks related to the implant include pain/pressure, movement of the implant (within or out of the sinus) and potential side effects of steroids. For more information on the risks and benefits of PROPEL sinus implants, talk to your doctor or review the FDA approved labeling at www.IntersectENT.com/technologies. Rx only.